“TOWARDS AN HIV CURE”: IAS 2013 SYMPOSIUM (JUNE 2013)
Under the auspices of the International AIDS Society, an international working group of researchers developed a Global Scientific Strategy “Towards an HIV Cure”, which was launched at a scientific symposium immediately preceding the XIX International AIDS Conference in Washington, DC in July 2012. The symposium, which received positive scientific feedback, provided a platform to present state-of-the-art basic science and clinical research on the HIV cure research priority areas defined in the strategy.
Following the publication of the Global Scientific Strategy in Nature Reviews Immunology and the success of the symposium, the IAS and the “Towards an HIV Cure” Advisory Board will convene another 2-day pre-conference symposium immediately prior to the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur in June 2013.
The symposium, co-chaired by Françoise Barré-Sinoussi, IAS President, Steven Deeks, Professor of Medicine at the University of California, San Francisco (UCSF), and Sharon Lewin, Director of the Infectious Diseases Unit, Alfred Hospital, Monash University, will be closely linked to the IAS 2013 conference programme. It is anticipated that a second symposium will give further impetus to HIV cure research, whilst also offering a valuable opportunity for the attendees to share ideas, debate, and network among their peers.
- Develop knowledge on the priorities that future research must address in order to tackle HIV persistence in patients on ART.
- Accelerate research on viral reservoirs as the way towards achieving a cure for HIV infection
- Provide an opportunity for scientists who are working on HIV cure to share ideas, debate, and network among their peers
- Promote increased investments in HIV/AIDS cure research
- Provide a platform for information-sharing between scientists, clinicians, funders, media and members of civil society.
How to attend the symposium
The symposium is open to senior, mid-career and junior scientists, clinical researchers, scientific journalists, research funding administrators and community representatives.
The capacity is limited to 300 participants. If you are interested in taking part, you can:
- Submit abstracts on IAS 2013 website
The IAS invites submission of abstracts pertinent to the development of an HIV cure, and sessions will be organized at IAS 2013 to report on the highlights of the symposium. All relevant abstracts in basic science, clincial studies and social sciences submitted to the IAS 2013 Conference can be considered for oral or poster presentation at the symposium.
Selected abstract presenters can be awarded scholarships to both the symposium and the IAS 2013 conference.
Abstract submission is now closed. Late breaker submissions will also be considered for the symposium; submission open between 3 April and 7 May 2013.
Abstract submitters must indicate that they would like their abstract to be considered for the “Towards an HIV Cure” pre-conference symposium using the opt-in tick-box on the submission page
- Request a registration on IAS website
If you would like to attend the scientific symposium “Towards an HIV Cure”, you must apply online. Registration is still open. Confirmations will be sent in April, after the abstracts are selected.
Please click here for more detailed information on the background and objectives of this initiative and for any additional information please contact .
IAS-ANRS Prize on HIV Cure
The US$2,000 IAS/ANRS Young Investigator Award will be awarded to an abstract presenter at the symposium. The award is jointly funded by the IAS and the Agence Nationale de Recherche sur le sida et les hépatites virales (ANRS) to support young researchers who demonstrate innovation, originality, rationale and quality in the field of HIV/AIDS research.
The Symposium Programme Committee
- Adeeba Kamarulzaman, University of Malaya, Malaysia
- Bruno Spire, Inserm, France
- Daniel Kuritzkes, Harvard Medical School, USA
- David Margolis, University of North Carolina, USA
- Doug Richman, University of California, San Diego, USA
- Françoise Barré-Sinoussi, Institut Pasteur, France
- Jintanat Ananworanich, The Thai Red Cross AIDS Research Centre, Thailand
- Nicolas Chomont, VGTI-Florida, USA
- Paula Cannon, University of Southern California, USA
- Richard Koup, NIAID, USA
- Sharon Lewin, Monash University, Australia
- Steven Deeks, University of California San Francisco, USA
7 May 2013
With the support of: